Truecare Biomedix Docusate Export Data — India (DGFT 2022–2026)

Name: Truecare Biomedix Docusate Export Records India — #1 Exporter, 136 Shipments, $5.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Docusate

India Pharmaceutical Trade Intelligence

$9.3M25 Suppliers35 CountriesHS 30049039

ExportsIndia → UNITED STATES84.6%India → AUSTRALIA12.9%

ImportsUNITED KINGDOM → India$324 JAPAN → India$71

#1 Supplier: TRUECARE BIOMEDIX #1 Buyer: PL DEVELOPMENTS

Truecare Biomedix — Docusate Exporter #1 | $5.9M Trade Value | TransData Nexus | TransData Nexus

Truecare Biomedix — Docusate Exporter Profile

Indian Pharmaceutical Exporter · #1 for Docusate · $5.9M export value · DGFT Verified

Truecare Biomedix is the #1 Indian exporter of Docusate with $5.9M in export value and 136 verified shipments. Truecare Biomedix holds a 63.2% market share in Docusate exports across 1 countries. The company exports 4 pharmaceutical products worth $12.0M across 3 therapeutic categories.

Truecare Biomedix — Docusate Export Profile: Buyers & Destinations

Truecare Biomedix Docusate export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Docusate?

Country	Value	Shipments	Share
UNITED STATES	$7.8M	234	84.6%
AUSTRALIA	$1.2M	81	12.9%
CANADA	$134.6K	12	1.5%
VENEZUELA	$28.3K	1	0.3%

Who Are the Top Buyers of Docusate from India?

Buyer	Country	Value	Orders
PL DEVELOPMENTS	UNITED STATES	$5.0M	99
GERICARE PHARMACEUTICALS CORP.	UNITED STATES	$1.2M	32
GENERIC HEALTH	AUSTRALIA	$371.2K	11
APOTEX AUSTRALIA	AUSTRALIA	$329.2K	34
GERICARE PHARMACEUTICALS CORP	UNITED STATES	$300.0K	6
NOUMED PHARMACEUTICALS PTY LTD	AUSTRALIA	$172.6K	10
NOUMED PHARMACEUTICALS PTY LIMITED	AUSTRALIA	$148.3K	12
GERICARE PHARMACEUTICALS	UNITED STATES	$145.8K	6
STRIVE PHARMACEUTICALS	UNITED STATES	$141.3K	8
PRIVATE LIMITED DEVELOPMENTS	UNITED STATES	$100.0K	2

India's Docusate is purchased by 158 buyers worldwide. The top buyer is PL DEVELOPMENTS (UNITED STATES), followed by GERICARE PHARMACEUTICALS CORP. and GENERIC HEALTH.

How Does Truecare Biomedix Compare to Nearest Docusate Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	TRUECARE BIOMEDIX ★	$5.9M	136	1	$43.0K
2	TRUE CARE BIOMEDIX	$950.0K	19	1	$50.0K
3	CIPLA LIMITED	$740.0K	65	1	$11.4K

Truecare Biomedix ranks #1 among 25 Indian Docusate exporters. Average shipment value of $43.0K compared to the market average of $353.6K. The closest competitors by value are TRUE CARE BIOMEDIX and CIPLA LIMITED.

Which Indian Ports Ship Docusate Exports?

Port	Shipments	% Share
SAHAR AIR	79	17.4%
MUNDRA SEA	68	15.0%
MUNDRA SEA (INMUN1)	50	11.0%
SAHAR AIR CARGO ACC (INBOM4)	48	10.6%
Bombay Air	20	4.4%
JNPT	17	3.8%
JNPT/ NHAVA SHEVA SEA	17	3.8%
AHEMDABAD ICD	16	3.5%

Geopolitical & Trade Policy Impact on Truecare Biomedix's Docusate Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Truecare Biomedix. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. These maritime challenges can affect the timely delivery of pharmaceuticals, particularly time-sensitive products, thereby impacting supply chain reliability. (pharmaceuticalcommerce.com)

Conversely, the ongoing US-China trade tensions have created openings for Indian exporters to strengthen their presence in the US market. With the United States accounting for 34% of India's pharmaceutical exports, companies like Truecare Biomedix have the opportunity to fill gaps left by reduced Chinese imports. (business-standard.com) However, this potential is tempered by the US administration's consideration of imposing tariffs on pharmaceutical imports, which could affect price competitiveness and market access. (business-standard.com)

In the European Union, regulatory changes such as the Falsified Medicines Directive (FMD) impose stringent compliance requirements on exporters. For Truecare Biomedix, adhering to these regulations is crucial to maintain and expand its market share in Europe, which constitutes 19% of India's pharmaceutical exports. (business-standard.com) Proactive engagement with EU regulatory bodies and investment in compliance infrastructure are essential to navigate this complex landscape.

Truecare Biomedix — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set rigorous quality benchmarks that companies must meet to access and sustain their presence in global markets.

India has made significant strides in this area, surpassing the US in the number of FDA-registered generic manufacturing sites, with 752 FDA-approved facilities as of 2024. (business-standard.com) For Truecare Biomedix, maintaining compliance with these standards is critical to ensure product quality, safety, and efficacy, thereby reinforcing its reputation as a reliable exporter. Continuous investment in quality assurance systems and staying abreast of evolving regulatory requirements are essential for sustaining and enhancing market access.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Docusate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Truecare Biomedix matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 35+ countries, 158+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Docusate

Docusate

Truecare Biomedix — Docusate Exporter Profile

Truecare Biomedix — Docusate Export Profile: Buyers & Destinations

Where Does India Export Docusate?

Who Are the Top Buyers of Docusate from India?

What Is India's Total Docusate Export Value and How Much Does Truecare Biomedix Contribute?

What Is the Average Shipment Value for Truecare Biomedix's Docusate Exports?

How Does Truecare Biomedix Compare to Other Indian Docusate Exporters?

Regulatory Requirements: Exporting Docusate to Key Markets

United States — FDA

Australia — TGA

How Does Truecare Biomedix Compare to Nearest Docusate Exporters?

Which Indian Ports Ship Docusate Exports?

Geopolitical & Trade Policy Impact on Truecare Biomedix's Docusate Exports

Truecare Biomedix — Regulatory Compliance & Quality Standards

About Truecare Biomedix

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Docusate Export Data from Truecare Biomedix

Docusate Stats

Company Overview

Top Products by Truecare Biomedix

Related Analysis

Need Detailed Export Data?

Data Source